Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab in Trigeminal Neuralgia
NCT04054024Phase 2Unknown
- Sponsor
- Dansk Hovedpinecenter
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of erenumab in trigeminal neuralgia (TN), sponsored by Dansk Hovedpinecenter. Status: unknown.
02
Drugs
erenumab
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT04054024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054024.